- US regulator approves $62.5 bn Bayer-Monsanto merger 10 April 2018
- Monsanto shareholders approve $66-bn acquisition by Bayer 14 December 2016
- Bayer, Versant Ventures to form JV for stem cell therapy technology 13 December 2016
- Bayer buys Monsanto for $66-bn to create a crop sciences giant 14 September 2016
- Bayer explores sale of dermatology business worth over $1.12 bn 09 September 2016
- Bayer raises offer for Monsanto to $127.50 a share as talks advance 06 September 2016
- Bayer raises takeover offer for Monsanto to $64 bn 15 July 2016
- Mallya to quit as chairman of Bayer CropScience 22 June 2016
- Bayer explores potential bid for Monsanto Co 13 May 2016
- Monsanto eyes Bayer's CropScience unit 21 March 2016
- US FDA approves Bayer's haemophilia therapy Kovaltry 18 March 2016
- Bayer weighs sale of diabetes device business worth up to $2.5 bn 25 November 2014
- Bayer mulls selling plastics unit worth $10.8 bn 28 April 2014
- Bayer close to bagging cancer drug maker Algeta for $2.9-bn 24 February 2014
- Bayer to acquire cancer drug maker Algeta 19 December 2013
- EU restrict pesticides use to protect bees 25 May 2013
- Bayer loses cancer drug patent case 04 March 2013
- Bayer clinches deal for sale of Thane land 30 November 2012
- Natco granted compulsory licence for Bayer's Nexavar 12 March 2012
- Bayer to continue focus on farm products with fresh capex 17 November 2011
- DB backs out of Bayer deal following Balwa arrest 12 February 2011
- Bayer opens emissions-neutral office building in India 21 January 2011
- Bayer to invest €1 bn in five projects in China 09 December 2010
- SC rejects Bayer plea against generic Cipla drug 02 December 2010
- Bayer develops raw materials for solar-powered refrigerators 26 August 2010
- Bayer CropScience board approves Thane land sale 20 July 2010
- Bayer CropScience halts work at Ankleshwar unit 26 March 2010
- Missouri court asks Bayer to pay $1.5 million damages to farmers 08 February 2010
- Bayer acquires global marketing rights for Durflex 03 February 2010
- Bayer to abandon haemophilia drug trial 25 January 2010
- Bayer receives European green award for its vehicle fleet 28 November 2009
- Bayer CropScience in early-stage research pact with GVK Biosciences 24 November 2009
- Bayer CropScience acquires Athenix or Bayer $365 million 03 November 2009
- Bayer to supply WHO with drug for African sleeping sickness 23 September 2009
- Delhi High Court allows Cipla to sell generic cancer drug 19 August 2009
- Bayer HealthCare acquires US consumer health firm Citracal 31 August 2007
- Bayer to transfer Exatec shares to Ge Plastics 29 August 2007
- Bayer recasts activities, gets into OTC sector 20 September 2002
- Ranbaxy to raise research spending to 6 per cent of sales by 2002 09 September 1999
- Bayer will restructure 19 March 1999
